UniProt ID | EFNA1_HUMAN | |
---|---|---|
UniProt AC | P20827 | |
Protein Name | Ephrin-A1 | |
Gene Name | EFNA1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 205 | |
Subcellular Localization |
Cell membrane Lipid-anchor, GPI-anchor . Ephrin-A1, secreted form: Secreted . |
|
Protein Description | Cell surface GPI-bound ligand for Eph receptors, a family of receptor tyrosine kinases which are crucial for migration, repulsion and adhesion during neuronal, vascular and epithelial development. Binds promiscuously Eph receptors residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. Plays an important role in angiogenesis and tumor neovascularization. The recruitment of VAV2, VAV3 and PI3-kinase p85 subunit by phosphorylated EPHA2 is critical for EFNA1-induced RAC1 GTPase activation and vascular endothelial cell migration and assembly. Exerts anti-oncogenic effects in tumor cells through activation and down-regulation of EPHA2. Activates EPHA2 by inducing tyrosine phosphorylation which leads to its internalization and degradation. Acts as a negative regulator in the tumorigenesis of gliomas by down-regulating EPHA2 and FAK. Can evoke collapse of embryonic neuronal growth cone and regulates dendritic spine morphogenesis.. | |
Protein Sequence | MEFLWAPLLGLCCSLAAADRHTVFWNSSNPKFRNEDYTIHVQLNDYVDIICPHYEDHSVADAAMEQYILYLVEHEEYQLCQPQSKDQVRWQCNRPSAKHGPEKLSEKFQRFTPFTLGKEFKEGHSYYYISKPIHQHEDRCLRLKVTVSGKITHSPQAHDNPQEKRLAADDPEVRVLHSIGHSAAPRLFPLAWTVLLLPLLLLQTP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
26 | N-linked_Glycosylation | DRHTVFWNSSNPKFR HCCEEECCCCCCCCC | 24.89 | 23661698 | |
96 | Phosphorylation | RWQCNRPSAKHGPEK CHHCCCCHHHHCHHH | 46.87 | 22964224 | |
98 | Ubiquitination | QCNRPSAKHGPEKLS HCCCCHHHHCHHHHH | 54.13 | 29967540 | |
103 | Ubiquitination | SAKHGPEKLSEKFQR HHHHCHHHHHHHHHH | 61.52 | 29967540 | |
107 | Ubiquitination | GPEKLSEKFQRFTPF CHHHHHHHHHHCCCC | 43.34 | 29967540 | |
115 | O-linked_Glycosylation | FQRFTPFTLGKEFKE HHHCCCCCCCCHHCC | 35.49 | OGP | |
118 | Acetylation | FTPFTLGKEFKEGHS CCCCCCCCHHCCCCC | 64.19 | 30588357 | |
118 | Ubiquitination | FTPFTLGKEFKEGHS CCCCCCCCHHCCCCC | 64.19 | 29967540 | |
126 | Phosphorylation | EFKEGHSYYYISKPI HHCCCCCEEEECCCC | 8.46 | - | |
128 | Phosphorylation | KEGHSYYYISKPIHQ CCCCCEEEECCCCCC | 7.18 | - | |
131 | Ubiquitination | HSYYYISKPIHQHED CCEEEECCCCCCCCC | 38.13 | 29967540 | |
146 | Phosphorylation | RCLRLKVTVSGKITH CEEEEEEEEECEECC | 13.84 | - | |
146 | O-linked_Glycosylation | RCLRLKVTVSGKITH CEEEEEEEEECEECC | 13.84 | 29237092 | |
150 | Ubiquitination | LKVTVSGKITHSPQA EEEEEECEECCCCCC | 36.60 | 29967540 | |
152 | Phosphorylation | VTVSGKITHSPQAHD EEEECEECCCCCCCC | 21.56 | 29396449 | |
152 | O-linked_Glycosylation | VTVSGKITHSPQAHD EEEECEECCCCCCCC | 21.56 | 55834111 | |
154 | Phosphorylation | VSGKITHSPQAHDNP EECEECCCCCCCCCH | 15.28 | 25159151 | |
154 | O-linked_Glycosylation | VSGKITHSPQAHDNP EECEECCCCCCCCCH | 15.28 | OGP | |
182 | GPI-anchor | VLHSIGHSAAPRLFP HHHHCCCCCCCCHHH | 22.40 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of EFNA1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of EFNA1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of EFNA1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CXCL7_HUMAN | PPBP | physical | 16169070 | |
EF1G_HUMAN | EEF1G | physical | 16169070 | |
KAT5_HUMAN | KAT5 | physical | 16169070 | |
EPHA4_HUMAN | EPHA4 | physical | 10366629 | |
XRCC6_HUMAN | XRCC6 | physical | 21900206 | |
CXCL7_HUMAN | PPBP | physical | 21900206 | |
GARE1_HUMAN | GAREM | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...